Immunoclin Corp Deferred Tax Assets, Valuation Allowance

Immunoclin Corp Deferred Tax Assets, Valuation Allowance

Immunoclin Corp had Deferred Tax Assets, Valuation Allowance of -$136.85 thousand as of 2014-06-30, per its 10-K filed 2014-07-07.

Discontinued › Notes › Income Taxes

us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2014-07-07

• 2014-06-30: Deferred Tax Assets, Valuation Allowance -$136.85K.
• 2013-01-31: Deferred Tax Assets, Valuation Allowance -$22.45K.